copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
A Study to Determine the Efficacy and Safety of Deucravacitinib . . . The purpose of this study is to evaluate the efficacy and safety of deucravacitinib versus placebo in participants with active psoriatic arthritis who are naïve to biologic disease-modifying anti-rheumatic drugs
A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and . . . Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections . . . Providence Facey Medical Foundation Mission Hills, California, 91345 Site Contact [email protected] 818-869-7067 San Diego, California Status Recruiting Arthritis Rheumatic Disease Specialties Aventura, Florida, 33180 Site Contact [email protected] 305-932-4162 Highlands Rheumatology, Avon Park, Florida Status
Biologic Drugs for Arthritis | Arthritis Foundation Learn about biologic medications used to treat autoimmune, inflammatory forms of arthritis and related conditions, their benefits, risks, side effects and how to safely use them
A Study of Nipocalimab in Adult Participants . . . - Arthritis Foundation Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages
A Study of Telitacicept for the Treatment of . . . - Arthritis Foundation Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease with heterogeneous manifestations and disease course Despite advances in medical care, there are still significant unmet needs in SLE with diminished health-related quality of life (HRQoL), persistent disease activity, disease flares, intolerance to standard of care (SOC) therapies, and development of organ damage and co